SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-055737
Filing Date
2021-11-09
Accepted
2021-11-09 16:16:18
Documents
62
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q rna-10q_20210930.htm   iXBRL 10-Q 2061968
2 EX-10.2 rna-ex102_101.htm EX-10.2 88937
3 EX-31.1 rna-ex311_6.htm EX-31.1 10159
4 EX-31.2 rna-ex312_9.htm EX-31.2 10149
5 EX-32.1 rna-ex321_7.htm EX-32.1 6788
6 EX-32.2 rna-ex322_8.htm EX-32.2 6761
  Complete submission text file 0001564590-21-055737.txt   7449737

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA rna-20210930.xsd EX-101.SCH 56179
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rna-20210930_cal.xml EX-101.CAL 46170
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rna-20210930_def.xml EX-101.DEF 183924
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE rna-20210930_lab.xml EX-101.LAB 446166
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rna-20210930_pre.xml EX-101.PRE 333406
12 EXTRACTED XBRL INSTANCE DOCUMENT rna-10q_20210930_htm.xml XML 1162183
Mailing Address 10975 N. TORREY PINES RD., #150 LA JOLLA CA 92037
Business Address 10975 N. TORREY PINES RD., #150 LA JOLLA CA 92037 858-401-7900
Avidity Biosciences, Inc. (Filer) CIK: 0001599901 (see all company filings)

IRS No.: 461336960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39321 | Film No.: 211392406
SIC: 2834 Pharmaceutical Preparations